-
Terbutaline
trade name
Brethine
-
Terbutaline
class
- Sympathomimetic Bronchodilator
- Tocolytic (in preterm labor)
-
Terbutaline
mechanism of action
- 1. Relaxes bronchial smooth muscle causing bronchodilation
- 2. Relaxes uterine smooth muscle inhibiting contractions
-
Terbutaline
indications
- 1. Moderate to severe asthma
- 2. Bronchospasms associated with COPD
- 3. Secondary to Magnesium Sulfate in preterm labor to inhibit contractions
-
Terbutaline
contraindications
Uncontrolled tachydysrythmias
-
Terbutaline
side effects
- Cardiovascular: palpitations, tachycardia, dysrhythmias, hypertension, PVCs
- Respiratory: paradoxical bronchospasm
-
Terbutaline
precautions
Use with cautions in patients with cardiac disease
-
Terbutaline
interactions
- 1. Beta Blockers will decrease the actions
- 2. MAO inhibitors may cause hypertensive crisis
-
Terbutaline
routes
SQ, IV, IO, IVPB
-
Terbutaline
onset and duration
Onset is immediate and may last 15 minutes
-
Terbutaline
dosages
- Adult:
- Bronchodilation: 0.25 mg SQ. May repeat once in 15-30 minutes
- Tocolytic: 10 mcg/min IV/IVPB titrated to a max of 80 mcg/min
Pediatric: 0.01 mg/kg SQ. Maximum dosage is 0.25 mg.
-
-
Fentanyl
trade name
Sublimaze
-
Fentanyl
class
narcotic analgesic
-
Fentanyl
mechanism of action
Provides analgesia and sedation by acting on the opiate receptors in the brain, blocking sensation of pain.
-
Fentanyl
indications
- 1. sedation during rapid sequence intubation
- 2. control severe pain
-
Fentanyl
contraindications
- 1. patients who have received MAO inhibitors in the last 14 days
- 2. myasthenia gravis
- 3. safe use in pregnancy and in children < 2 years old not established
-
Fentanyl
side effects
- CNS: sedation, euphoria, dizziness, diaphoresis, seizures with high doses, delirium
- Cardiovascular: hypotension, bradycardia, circulatory depression, cardiac arrest
- Respiratory: respiratory depression or arrest, bronchoconstriction, laryngospasm
- GI: nausea/vomiting, constipation
-
Fentanyl
precautions
Use with caution in head injuries, suspected or known increased intracranial pressure; the elderly, debilitated or immuno-compromised patients; COPD or other respiratory problems and those with kidney or liver dysfunction.
-
Fentanyl
interactions
Alcohol and other CNS depressants potentiate effects of fentanyl; MAO inhibitors may precipitate hypertensive crisis.
-
Fentanyl
routes
IV, IO, IM (also found in home medication form in the transdermal patch)
-
Fentanyl
onset and duration
Onset is immediate; peak effect in 3-5 min IV, 5-15 IM; duration is 30-60 minutes (or hours with transdermal patch).
-
Fentanyl
dosages
- Adult: 25-100 mcg SLOW IV push (over 2-3 minutes)
- Pediatric (child > 2 years): 2.0 mcg/kg SLOW IV push or IM
-
Fentanyl
notes
Fentanyl provides much faster acting, more prolonged pain relief. Duration of respiratory depressant effects may be significantly longer than analgesic effects – always have oxygen immediately available and be prepared with intubation equipment and a narcotic antagonist (i.e. naloxone).
-
Lorazepam
trade name
Ativan
-
Lorazepam
class
- Benzodiazepine
- Sedative
- Anti-anxiety (anxiolytic)
-
Lorazepam
mechanism of action
Most potent of all Benzodiazepines; its effects (anxiolytic, sedative, hypnotic, and skeletal muscle relaxant) are all mediated by increasing the levels of the inhibitory neurotransmitter GABA. GABA works mostly at the hypothalamus, limbic system and thalamus in the brain.
-
Lorazepam
indications
- 1. status epilepticus
- 2. sedation prior to cardioversion/pacing
- 3. anxiety
-
Lorazepam
contraindications
- 1. pregnancy or nursing mothers
- 2. Use with caution in shock, coma, acute alcohol intoxication, suicidal patients and those with depressed respirations.
-
Lorazepam
side effects
CNS: Anterograde amnesia, drowsiness, sedation, dizziness/disorientation, confusion, Hallucinations (found frequently in elderly patients), restlessness
Cardiovascular: hypertension or hypotension
GI: nausea/vomiting, abdominal discomfort
Other: depressed hearing
-
Lorazepam
precautions
Use further care when administering Ativan to patients with renal or hepatic impairment; the elderly or debilitated; and those with psychosis
-
Lorazepam
interactions
Alcohol, CNS depressants, and anticonvulsants may potentiate CNS depression; may also increase Dilantin levels; and smoking decreases sedative and anti-anxiety effects.
-
Lorazepam
routes
IV, IO, IM, PR
-
Lorazepam
onset and duration
Onset is 1-5 min IV, 15-30 min IM; peak effects in 15-20 mins IV, 2 hrs IM; duration 6-8 hours.
-
Lorazepam
dosages
- Sedation for Cardioversion:
- Adult: 2-4 mg IM, or 0.5-2 mg IV
- Pediatric: 0.03 mg-0.05 mg/kg IV/IM/PR max dose of 4mg
- Seizure Management:
- Adult: 2 mg slow IV (1mg/min) – repeat half dose if needed in 2-5 mins
- Pediatric: 0.1 mg/kg slow IV (over 2-5 mins); repeat half dose if needed in 2-5 minutes (Can be given PR to children if no IV obtained)
Riverside County Protocol: Not in Riverside County Protocol
-
Lorazepam
notes
Keep benzodiazepine antagonist (i.e. Romazicon) nearby; patient over 50 years of age have frequent incidents of psychosis with Ativan administration do exceed 2 mg initial dose
-
-
Haloperidol
trade name
- antipsychotic
- tranquilizer
-
Haloperidol
mechanism of action
- 1. demonstrates anti-psychotic effects by blocking dopamine receptors in the brain (dopamine receptors are linked to mood and behavior)
- 2. exerts strong anti-emetic effects and impairs central thermoregulation
-
Haloperidol
indications
- 1. acute psychotic disorders/episodes
- 2. delirium
-
Haloperidol
contraindications
- 1. Parkinson’s Disease
- 2. seizure disorders
- 3. coma
- 4. alcoholism
- 5. ALOC
- 6. Safe use during pregnancy, in nursing mothers, and in children < 3 years has not been established
-
Haloperidol
side effects
- CNS: Extrapyramidal reactions, dystonia, restlessness, reflexive anxiety, Combativeness (particularly in elderly patient administration)
- Cardiovascular: tachycardia, hypotension, ECG changes
- GI: dry mouth, constipation, diarrhea, N/V
- Respiratory: respiratory depression, bronchospasm
-
-
Haloperidol
precautions
Use with caution in elderly or debilitated patients or those with severe Cardiovascular disorders.
-
Haloperidol
interactions
CNS depressants, opiates and alcohol may increase CNS depression, may also antagonize oral anti-coagulants
-
Haloperidol
routes
IM, PO (in inpatient care settings)
-
Haloperidol
onset and duration
Onset in 10-45 minutes; peak effect in 10-20 min, can last up to 36 hours.
-
Haloperidol
dosage
- Adult: 2-5 mg IM
- Pediatric: 0.05-0.15 mg/kg/day PO typically divided into 2 or 3 doses
-
Hydromorphone Hydrochloride
trade name
Dilaudid
-
Hydromorphone Hydrochloride
class
Narcotic Analgesic
-
Hydromorphone Hydrochloride
mechanism of action
- 1. Binds with opiate receptors in brain, altering perception and emotional response to pain.
- 2. suppresses the cough reflex by direct action on the cough center in the medulla oblongata.
-
Hydromorphone Hydrochloride
indications
- 1. moderate to severe pain
- 2. persistent cough
-
Hydromorphone Hydrochloride
contraindications
- 1. increased intracranial pressure
- 2. respiratory depression / inadequacy – such as in COPD, status asthmaticus
- 3. circulatory compromise
-
Hydromorphone Hydrochloride
side effects
- CNS: sedation, dizziness, lightheadedness, somnolence, blurred vision, nystagmus
- Cardiovascular: hypotension, bradycardia
- Respiratory: respiratory depression or arrest, bronchospasm
- GI: nausea / vomiting, constipation
-
Hydromorphone Hydrochloride
precautions
Use with caution in head injuries; the elderly, debilitated or immuno-compromised patients; COPD or other respiratory problems and those with kidney or liver dysfunction.
-
Hydromorphone Hydrochloride
interactions
Other CNS depressants, general anesthetics, MAO inhibitors, other opioid analgesics, sedatives, tranquilizers, and tricyclic antidepressants may potentiate the effects of Dilaudid.
-
Hydromorphone Hydrochloride
routes
IV, IO, IM, SQ, PR and PO
-
Hydromorphone Hydrochloride
onset and duration
IV and IM administration most common in the hospital setting – IV: onset in 10-15 minutes, peaks in 15-30 minutes and lasts 2-3 hours. IM: onset in 15 minutes, peaks in 30-60 minutes, and lasts 4-5 hours.
-
Hydromorphone Hydrochloride
dosage
- For Pain Control:
- Adults: 1-4 mg IM, SQ or SLOW IV push (over at least 2-5 minutes) every 4-6 hours
- Pediatrics: Rarely given for pain control – primarily for cough suppressant effects.
- For Cough:
- Adults and children > 12 years: 1 mg cough syrup PO every 3-4 hours
- Children ages 6-12 years: 0.5 mg of cough syrup every 3-4 hours
-
Hydromorphone Hydrochloride
notes
Often used in the clinical internship setting.
|
|